Silverback Therapeutics, Inc. Intellectual Property Contracts & Agreements

4 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License and Supply Agreement, dated as of September 21, 2020, by and between ARS Pharmaceuticals, Inc. and Recordati Ireland, Ltd
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
License Agreement, dated as of June 18, 2018, by and between ARS Pharmaceuticals, Inc. and Aegis Therapeutics, LLC, as amended by the First Amendment to License Agreement, dated...
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
Amendment No. 1 to Cell Line License Agreement, by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated January 12, 2021
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
2021
Cell Line License Agreement, by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated October 11, 2019
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2020